Aryn Sands
@Bml Capital Management, Llc
Latest period2024 - Q3ReportedManaged Assets$169.95MTotal holdings29
Assets growth rate21.28%Assets growth rate (2-Q avg)6.84%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Bml Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 29 positions.
Assets under management
The assets under management (AUM) of Bml Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 169.95M in assets, with a quarterly growth rate of 21.28% and a 2-quarter average growth rate of 6.84%. The portfolio is managed by Aryn Sands, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
PIRSPieris Pharmaceuticals Inc
| 0.42% | $698,515 42,130 shares@ $16.58 avg price | New Position |
CALCCalcimedica Inc
| 0.41% | $681,719 153,887 shares@ $4.43 avg price | Decreased -4.07% |
ALVRAllovir Inc
| 0.29% | $487,595 603,086 shares@ $0.81 avg price | |
TLISTalis Biomedical Corp
| 0.28% | $460,099 248,702 shares@ $1.86 avg price | Increased 481.86% |
VTGNVistagen Therapeutics Inc
| 0.27% | $451,500 150,000 shares@ $3.01 avg price | |
FBRXForte Biosciences Inc
| 0.24% | $393,916 70,468 shares@ $5.59 avg price | New Position |
NXTCNextcure Inc
| 0.23% | $378,757 276,465 shares@ $1.37 avg price | |
VRCAVerrica Pharmaceuticals Inc
| 0.16% | $261,000 180,000 shares@ $1.45 avg price | |
HLVXHillevax Inc
| 0.03% | $34,778 19,760 shares@ $1.77 avg price | New Position |